| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antibody therapy for treatment or prevention of infectious diseases
|
Kokai-Kun, John F.
|
|
2004
|
1 |
4 |
p. 475-481
7 p.
|
artikel
|
| 2 |
Anti-infective pharmacodynamics – maximizing efficacy, minimizing toxicity
|
Jacobs, Michael R.
|
|
2004
|
1 |
4 |
p. 505-512
8 p.
|
artikel
|
| 3 |
Blocking viral entry: a complementary strategy for HIV therapy
|
Jiang, Shibo
|
|
2004
|
1 |
4 |
p. 497-503
7 p.
|
artikel
|
| 4 |
Cancer chemoprevention: myth or reality?
|
Mann, Jason R.
|
|
2004
|
1 |
4 |
p. 403-409
7 p.
|
artikel
|
| 5 |
Contents
|
|
|
2004
|
1 |
4 |
p. i-ii
nvt p.
|
artikel
|
| 6 |
Enzymes for anti-infective therapy: phage lysins
|
López, Rubens
|
|
2004
|
1 |
4 |
p. 469-474
6 p.
|
artikel
|
| 7 |
Finding the gems using genomic discovery: antibacterial drug discovery strategies – the successes and the challenges
|
Chan, Pan F.
|
|
2004
|
1 |
4 |
p. 519-527
9 p.
|
artikel
|
| 8 |
Formulation design: new drugs from old
|
Crowley, Patrick J.
|
|
2004
|
1 |
4 |
p. 537-542
6 p.
|
artikel
|
| 9 |
HIV resistance and the effectiveness of combination antiretroviral treatment
|
Mugavero, Michael J.
|
|
2004
|
1 |
4 |
p. 529-535
7 p.
|
artikel
|
| 10 |
Mining the genome with RNAi to select cancer drug targets
|
Kan, Julie L.C.
|
|
2004
|
1 |
4 |
p. 397-401
5 p.
|
artikel
|
| 11 |
Network-targeted combination therapy: a new concept in cancer treatment
|
Araujo, Robyn P.
|
|
2004
|
1 |
4 |
p. 425-433
9 p.
|
artikel
|
| 12 |
New approaches to Clostridium difficile colitis therapy
|
Rogers, Bruce L.
|
|
2004
|
1 |
4 |
p. 513-517
5 p.
|
artikel
|
| 13 |
Recent advances in the treatment of Gram-positive infections
|
Coleman, Ken
|
|
2004
|
1 |
4 |
p. 455-460
6 p.
|
artikel
|
| 14 |
Targeted therapies for cancer – from tamoxifen to gefitinib (‘Iressa’)
|
Hanke, Jeffrey H.
|
|
2004
|
1 |
4 |
p. 411-416
6 p.
|
artikel
|
| 15 |
Targeting the cell cycle
|
Fischer, Peter M.
|
|
2004
|
1 |
4 |
p. 417-423
7 p.
|
artikel
|
| 16 |
Targeting virulence to prevent infection: to kill or not to kill?
|
Alekshun, Michael N.
|
|
2004
|
1 |
4 |
p. 483-489
7 p.
|
artikel
|
| 17 |
The challenge of developing an effective HIV-1 vaccine
|
Imami, Nesrina
|
|
2004
|
1 |
4 |
p. 461-467
7 p.
|
artikel
|
| 18 |
The combination of cytotoxic and molecularly targeted therapies – can it be done?
|
Jackman, Ann L.
|
|
2004
|
1 |
4 |
p. 445-454
10 p.
|
artikel
|
| 19 |
Tuberculosis – strategies towards anti-infectives for a chronic disease
|
Barry III, Clifton E.
|
|
2004
|
1 |
4 |
p. 491-496
6 p.
|
artikel
|
| 20 |
Use of metabolic pathway flux information in targeted cancer drug design
|
Boros, László G.
|
|
2004
|
1 |
4 |
p. 435-443
9 p.
|
artikel
|
Tijdschrift beschrijving